Impact of Donor Core Body Temperature on Graft Survival After Heart Transplantation

被引:11
|
作者
Schnuelle, Peter [1 ,2 ]
Benck, Urs [2 ]
Kraemer, Bernhard K. [2 ]
Yard, Benito A. [2 ]
Zuckermann, Andreas [3 ]
Wagner, Florian [4 ]
Szabo, Gabor [5 ]
Borggrefe, Martin [6 ,7 ]
Karck, Matthias [5 ]
Gummert, Jan [8 ]
机构
[1] Ctr Renal Dis, Acad Training Practice, Weinheim, Germany
[2] Univ Med Ctr Mannheim, Dept Med 5, Mannheim, Germany
[3] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria
[4] Asklepios Clin St Georg, Dept Cardiac Surg, Hamburg, Germany
[5] Univ Hosp Heidelberg, Dept Cardiac Surg, Heidelberg, Germany
[6] Univ Med Ctr Mannheim, Dept Med 1, Mannheim, Germany
[7] German Ctr Cardiovasc Res Heidelberg Mannheim, Mannheim, Germany
[8] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Dept Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany
关键词
MILD INDUCED HYPOTHERMIA; N-OCTANOYL DOPAMINE; THERAPEUTIC HYPOTHERMIA; KIDNEY-TRANSPLANTATION; MYOCARDIAL-INFARCTION; CARDIAC-ARREST; BRAIN-DEATH; CALCIUM; PRESERVATION; PRETREATMENT;
D O I
10.1097/TP.0000000000002337
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background A previous donor intervention trial found that induction of mild therapeutic hypothermia in the brain-dead donor reduced the dialysis requirement after kidney transplantation. Consequences on the performance of cardiac allografts after transplantation were not explored to date. Methods Cohort study investigating 3-year heart allograft survival according to spontaneous core body temperature (CBT) assessed on the day of organ procurement. The study is nested in the database of the randomized trial of donor pretreatment with low-dose dopamine (ClinicalTrials.gov identifier: NCT000115115). Results Ninety-nine heart transplant recipients who had received a cardiac allograft from a multiorgan donor enrolled in the dopamine trial were grouped by tertiles of the donor's CBT assessed by a mere temperature reading 4 to 20 hours before procurement (lowest, 32.0-36.2 degrees C; middle, 36.3-36.8 degrees C; highest, 36.9-38.8 degrees C). Baseline characteristics considering demographics of donors and recipients, concomitant donor treatments, donor hemodynamic, and respiratory parameters as well as underlying cardiac diseases in recipients, pretransplant hemodynamic assessments, including pretransplant inotropic/mechanical support, urgency, and waiting time were similar. A lower CBT was associated with inferior heart allograft survival (hazard ratio, 0.53; 95% confidence interval, 0.31-0.93, per tertile; P = 0.02, and hazard ratio, 0.68; 95% confidence interval, 0.50-0.93 degrees C; P = 0.02) when CBT was included as continuous explanatory variable in the Cox regression analysis. Conclusions A lower CBT in the brain-dead donor before procurement may associate with an unfavorable clinical course after heart transplantation. More research is required, before therapeutic hypothermia can routinely be used in multiorgan donors when a cardiac transplantation is intended.
引用
收藏
页码:1891 / 1900
页数:10
相关论文
共 50 条
  • [41] Donor Desmopressin Is Associated With Superior Graft Survival After Kidney Transplantation
    Benck, Urs
    Gottmann, Uwe
    Hoeger, Simone
    Lammert, Alexander
    Rose, Daniela
    Boesebeck, Detlef
    Lauchart, Werner
    Birck, Rainer
    Weiss, Christel
    Kraemer, Bernhard K.
    Yard, Benito A.
    Schnuelle, Peter
    [J]. TRANSPLANTATION, 2011, 92 (11) : 1252 - 1258
  • [42] Impact of Donor Cause of Death on Graft Utilization in Pediatric Heart Transplantation
    Khan, A. M.
    Malerba, S.
    Bock, M.
    Lytrivi, I.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S72 - S72
  • [43] Recipient body mass index and age interact to impact survival after heart transplantation
    Weber, Daniel J.
    Hashmi, Zubair A.
    Gracon, Adam S. A.
    Hellman, Yaron M.
    Patel, Ankur J.
    Wozniak, Thomas C.
    Wang, I-wen
    [J]. CLINICAL TRANSPLANTATION, 2014, 28 (11) : 1279 - 1286
  • [44] The Role of Donor Age and Gender on Survival after Heart Transplantation
    Weber, D. J.
    Didolkar, P.
    Gracon, A.
    Hellman, Y.
    Hadi, M. A.
    Malik, A.
    Caccamo, M.
    Gradus-Pizlo, I.
    Wozniak, T.
    Wang, I.
    Hashmi, Z. A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S63 - S63
  • [45] Impact of Donor and Recipient Cytomegalovirus Immune Status on Long-Term Graft Survival in Pediatric Heart Transplantation
    Rabbani, Naveed
    Kronmal, Richard
    Albers, Erin L.
    Friedland-Little, Joshua
    Hong, Borah
    Kemna, Mariska
    Law, Yuk M.
    [J]. CIRCULATION, 2020, 142
  • [46] The Impact of Donor-Recipient Age Difference on Graft Survival after Heart Transplant in Adults with Congenital Heart Disease
    Marshall, W. H.
    Nandi, D.
    Daniels, C. J.
    Wright, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S131 - S132
  • [47] Survival After Orthotopic Liver Transplantation: The Impact of Antibody Against Hepatitis B Core Antigen in the Donor
    Yu, Lei
    Koepsell, Thomas
    Manhart, Lisa
    Ioannou, George
    [J]. LIVER TRANSPLANTATION, 2009, 15 (10) : 1343 - 1350
  • [48] Non-HLA autoantibodies supplement donor specific antibodies in predicting graft survival after heart transplantation
    Oh, G.
    Lee, H. -Y.
    Song, E. Y.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [49] Donor and Recipient Cytokine Profiles Predict Acute Rejection and Graft-Related Survival After Heart Transplantation
    Holmstrom, E.
    Syrjala, S.
    Dhaygude, K.
    Tuuminen, R.
    Krebs, R.
    Nykanen, A.
    Lemstrom, K.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S154 - S154
  • [50] Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor
    Yu, Lei
    Koepsell, Thomas
    Ioannou, George
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A804 - A804